Personalising care in oesophageal cancer care with liquid biopsy.

De Paula, Bruno; C Smyth, Elizabeth

De Paula, Bruno; C Smyth, Elizabeth.

Afiliação

De Paula B; Department of Oncology, University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
C Smyth E; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Elizabeth.Smyth@addenbrookes.nhs.uk.

Br J Cancer ; 125(8): 1036-1038, 2021 10.

Article em En | MEDLINE | ID: mdl-33931744

RESUMO

The advent of ctDNA has the potential to be a game changer in some cancers, but limited data is available in oesophago-gastric cancers (OGC). The prognostic value of ctDNA and the potential for false positive results due to clonal haematopoiesis of indeterminate potential (CHIP) was recently reported in operable OGC.

Assuntos

DNA Tumoral Circulante/genética; Neoplasias Esofágicas/genética; Neoplasias Esofágicas/sangue; Humanos; Biópsia Líquida; Medicina de Precisão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / DNA Tumoral Circulante Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google